Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationLiver TransplantationTransplantation ConditioningStem Cell TransplantationMultiple MyelomaHematopoietic Stem CellsKidney TransplantationHematopoietic Stem Cell MobilizationMelphalanAntigens, CD34Graft SurvivalStem CellsPeripheral Blood Stem Cell TransplantationCell TransplantationTreatment OutcomeCombined Modality TherapyLymphoma, Non-HodgkinHeart TransplantationBone Marrow PurgingGranulocyte Colony-Stimulating FactorSalvage TherapyLung TransplantationLeukapheresisCarmustineRecurrenceWhole-Body IrradiationCyclophosphamideGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsCell DifferentiationRemission InductionBone Marrow CellsDisease-Free SurvivalOrgan TransplantationColony-Forming Units AssayEtoposideSurvival AnalysisCells, CulturedHematopoiesisBone MarrowBusulfanHodgkin DiseaseRetrospective StudiesTime FactorsHematologic NeoplasmsBlood Transfusion, AutologousGraft RejectionImmunosuppressive AgentsSurvival RateCytarabinePancreas TransplantationIslets of Langerhans TransplantationTissue DonorsCell SeparationTransplantation ImmunologyTransplantationFollow-Up StudiesGraft vs Tumor EffectTransplantation ChimeraMyeloablative AgonistsKanamycin KinaseThalidomideBlood Component RemovalCell LineageFlow CytometryCell Culture TechniquesTransplantation, IsogeneicFeasibility StudiesVincristinePrognosisGenetic TherapyBlood Cell CountMyeloid Progenitor CellsCord Blood Stem Cell TransplantationLymphomaNeoplasm, ResidualAntigens, CDLeukemiaLeukemia, Myeloid, AcuteTransplantation, HeterotopicImmunomagnetic SeparationLiving DonorsIdarubicinTransduction, GeneticGenetic VectorsMyelodysplastic SyndromesAntineoplastic Agents, AlkylatingPrednisoneDexamethasoneLentivirusHeart-Lung TransplantationMice, Inbred C57BLAntibodies, MonoclonalImmunosuppressionFetal Tissue TransplantationProspective StudiesTransplantation Tolerance